Hetero Drugs Ltd · 66-66 · INDIA
For Hetero Drugs Ltd · 66-66 · INDIA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is INDIA; product is Doxazosin Mesylate; product code is 62 O - S 27 Doxazosin Mesylate (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 7 1 Hetero House # 8 - 3 - 166 , Hyderabad, Telangana INDIA, verified against its source on 2026-09-16.
- Firm
- Hetero Drugs Ltd verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- INDIA verified
- Address
- 7 1 Hetero House # 8 - 3 - 166 , Hyderabad, Telangana INDIA verified
- Date published
- 09/30/2009 verified
- Product code
- 62 O - S 27 Doxazosin Mesylate (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf verified
- Product
- Doxazosin Mesylate verified
- FDA notes
- 10/3/2000 verified
What the source says
Hetero Drugs Ltd Date Published : 09/30/2009 7 1 Hetero House # 8 - 3 - 166 , Hyderabad, Telangana INDIA 62 O - S 27 Doxazosin Mesylate (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Doxazosin Mesylate Notes: 10/3/2000
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.